1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1. Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Adoption of highly effective methods for screening test processes.
4.1.2 Increasing awareness among the people and consumers.
4.1.3 Increase in pipeline breast cancer screening tests.
4.2. Restraints
4.2.1 Higher screening test process.
4.2.2 Economic uncertainty and reimbursement issues.
4.3. Opportunities
4.3.1 Newer technological developments and approaches.
4.4. Challenges
4.4.1. Innovative medicines and new mechanisms of action to enhance the enthusiasm about major approaches in cancer treatments.
5. Global Breast Cancer Screening Test Market - By Tests
5.1 Introduction
5.2 Blood marker tests
5.3 Imaging tests
5.3.1 Mammograms
5.3.2 MRI
5.3.3 Ultrasound
5.3.4 Mamma print test
5.4 Genetic tests
5.4.1 Fluorescence in-situ hybridisation
5.4.2 HER gene test
5.5 Immunohistochemistry
6. Global Breast Cancer Screening Test Market - By End-user
6.1 Introduction
6.2 Hospitals
6.3 Diagnostics centres
6.4 Cancer institutes
6.5 Research laboratories
7.Global Breast Cancer Screening Test Market – By Country
7.1 North America
7.1.1 Introduction
7.1.2 United States
7.1.3 Canada
7.1.4 Mexico
7.1.5 Others
7.2 Europe
7.2.1 Introduction
7.2.2 France
7.2.3 Germany
7.2.4 Italy
7.2.5 United Kingdom
7.2.6 Spain
7.2.7 Russia
7.2.8 Others
7.3 Asia-pacific
7.3.1 Introduction
7.3.2 China
7.3.3 Japan
7.3.4 India
7.3.5 Australia
7.3.6 Others
7.4 South America
7.4.1 Introduction
7.4.2 Brazil
7.4.3 Argentina
8. Global Breast Cancer Screening Test Market - Company Profiles
8.1 A&G Pharmaceutical, Inc.
8.2 Armune Bioscience, Inc.
8.3 Genomic Health, Inc.
8.4 Agendia BV
8.5 BioMark Technologies Inc.
8.6 Abcodia Ltd.
8.7 Metabolomic Technologies Inc.
8.8 Biocrates Life Sciences AG
8.9 Insight Genetics, Inc.
8.10 Quest Diagnostics Incorporated
8.11 Siemens Healthcare Diagnostics Inc.
8.12 HTC Molecular Diagnostics Inc.
8.13 Panacea Pharmaceuticals, Inc.
8.14 Chronix Biomedical, Inc.
8.15 Roche Diagnostics Limited
8.16 Nuclea Biotechnologies Inc
9. Global Breast Cancer Screening Market - Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
10.Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
11.Appendix
11.1. List of tables
11.2. List of figures
